Izvorni znanstveni članak
Bone mineral content in patients with myasthenia gravis treated with cortisone
M. Harmut
; Institute for Medical Research and Occupational Health, Zagreb, Croatia
V. Kušec
; Institute for Medical Research and Occupational Health, Zagreb, Croatia
I. Matulić-Bedenić
; Faculty of Machine Engineering and Shipbuilding, Zagreb, Croatia
A. Jušić
; Centre for Neuromuscular Diseases, Medical Faculty, Zagreb, Croatia
Sažetak
Bone mineral content (BMC) was measured in 23 patients with myasthenia gravis using the 241Am gamma ray attenuation method. Measurements were performed in the proximal (BMC6) and distal (BMC1) parts of the forearm, i.e. at 6 and 1 cm distance from the styloid process of the ulna in supine position. At 6 cm from the styloid process the bone is mostly compact, whereas at 1 cm distance it is mostly trabecular. The results were compared with the BMC values in age and sex matched controls. No signs of major bone loss were noticed in any of the myasthenic patients examined in spite of prolonged administration of fluorocortolone.
Ključne riječi
Hrčak ID:
152470
URI
Datum izdavanja:
15.6.1989.
Posjeta: 804 *